TY  - JOUR 
AU  - Gil Julio, Hernani
AU  - Ramírez González, Amanda Rocío
AU  - Aptsiauri, Natalia
AU  - Ruiz-Cabello Osuna, Francisco
PY  - 2021
UR  - http://hdl.handle.net/10481/69590
AB  - Cancer eradication and clinical outcome of immunotherapy depend on tumor cell immunogenicity, including HLA class I (HLA-I) and PD-L1 expression on malignant cells, and on
the characteristics of the tumor microenvironment, such as tumor immune...
LA  - eng
PB  - MDPI
KW  - Bladder cancer
KW  - HLA class I
KW  - Cancer immune escape
KW  - Tumor infiltrating lymphocytes (TILs)
KW  - T-cell exclusion
KW  - PD-L1
KW  - Cancer associated fibroblasts
TI  - Tumor Escape Phenotype in Bladder Cancer Is Associated with Loss of HLA Class I Expression, T-Cell Exclusion and Stromal Changes
DO  - 10.3390/ijms22147248
ER  -